112 related articles for article (PubMed ID: 6337198)
1. Local intranasal immunotherapy for grass-allergic rhinitis.
Georgitis JW; Reisman RE; Clayton WF; Mueller UR; Wypych JI; Arbesman CE
J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):71-6. PubMed ID: 6337198
[TBL] [Abstract][Full Text] [Related]
2. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts.
Georgitis JW; Clayton WF; Wypych JI; Barde SH; Reisman RE
J Allergy Clin Immunol; 1984 Nov; 74(5):694-700. PubMed ID: 6389648
[TBL] [Abstract][Full Text] [Related]
3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.
Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB
J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy.
Bousquet J; Frank E; Soussana M; Hejjaoui A; Maasch HJ; Michel FB
Int Arch Allergy Appl Immunol; 1987; 82(3-4):550-2. PubMed ID: 3553031
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
8. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis.
Bozek A; Kolodziejczyk K; Warkocka-Szoltysek B; Jarzab J
Am J Rhinol Allergy; 2014; 28(5):423-7. PubMed ID: 25198030
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
Bertoni M; Cosmi F; Bianchi I; Di Berardino L
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
Bousquet J; Hejjaoui A; Soussana M; Michel FB
J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
12. Preseasonal intranasal immunotherapy with nebulized short ragweed extract.
Welsh PW; Zimmermann EM; Yunginger JW; Kern EB; Gleich GJ
J Allergy Clin Immunol; 1981 Mar; 67(3):237-42. PubMed ID: 7007474
[TBL] [Abstract][Full Text] [Related]
13. Local nasal immunotherapy with a powder extract for grass pollen induced rhinitis in pediatric ages: a controlled study.
Bardare M; Zani G; Novembre E; Vierucci A
J Investig Allergol Clin Immunol; 1996; 6(6):359-63. PubMed ID: 9015779
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
[TBL] [Abstract][Full Text] [Related]
15. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
[TBL] [Abstract][Full Text] [Related]
16. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
17. Controlled studies of intranasal immunotherapy for ragweed pollenosis.
Mathews KP; Bayne NK; Banas JM; McLean JA; Bacon J
Int Arch Allergy Appl Immunol; 1981; 66(2):218-24. PubMed ID: 6169652
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid.
Corrigan CJ; Kettner J; Doemer C; Cromwell O; Narkus A;
Allergy; 2005 Jun; 60(6):801-7. PubMed ID: 15876311
[TBL] [Abstract][Full Text] [Related]
19. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
20. Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study.
Deuschl H; Johansson GO
Acta Allergol; 1977 Aug; 32(4):248-62. PubMed ID: 578362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
